New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions
Stinging Insect Component Testing Combined with Interpretative Report Offers Enhanced Patient Management BURLINGTON, N.C.–(BUSINESS WIRE)–Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially life-threatening allergic reaction. To help facilitate more effective venom therapy, Labcorp (NYSE: LH), a … [Read more…]